Suppr超能文献

皮肤基底细胞癌中Claudin 1和Claudin 4的差异表达

Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin.

作者信息

Nakazawa T, Hasegawa A, Nagasaka T, Yoshida K, Guo F, Wu D, Hiroshima K, Takeuchi M

机构信息

Departments of Pathology, Tokyo Women's Medical University Yachiyo Medical Center (TYMC), Yachiyo, Chiba 276-8524, Japan.

Plastic Surgery, Tokyo Women's Medical University Yachiyo Medical Center (TYMC), Yachiyo, Chiba 276-8524, Japan.

出版信息

Dermatol Res Pract. 2023 Jan 20;2023:9936551. doi: 10.1155/2023/9936551. eCollection 2023.

Abstract

Basal cell carcinoma (BCC) is the most common human malignancy. The biological behavior of this entity is remarkably indolent. Claudin plays an important role in tight junctions, regulating paracellular passage of variable substance including growth factors and maintaining the polarity of epithelia. Up- or downregulated claudin expression has been reported in many cancers. Nevertheless, claudin expression in BCC of the skin remains unclear. We therefore examined the status of claudin 1 and 4 expressions in BCC and adjacent normal skin by immunohistochemistry (IHC). Our IHC results demonstrated high claudin 1 expression and low claudin 4 expression in 33 of 34 lower-grade BCCs. In lower-grade BCC, claudin 1 was increased and claudin 4 was decreased compared with the normal skin. Claudin 1 was inclined to be highly expressed in the membrane and cytoplasm of tumour cells in the periphery of tumour nest. Conversely, almost all lower-grade BCCs (33/34) and one of two higher-grade BCC lacked or showed focal positivity for claudin 4. These results imply that the expression pattern is characteristics of lower-risk BCC. Interestingly, one of the two higher-grade BCCs demonstrated the converse expression patterns of claudins, with decreased claudin 1 and increased claudin 4. The combination of immunohistochemical claudin 1 and 4 expression may offer a useful ancillary tool for the pathological diagnosis of BCC. Furthermore, membranous and intracellular claudins may present future therapeutic targets for uncontrollable BCC.

摘要

基底细胞癌(BCC)是最常见的人类恶性肿瘤。该实体的生物学行为非常惰性。闭合蛋白在紧密连接中起重要作用,调节包括生长因子在内的各种物质的细胞旁通道,并维持上皮细胞的极性。许多癌症中都报道了闭合蛋白表达的上调或下调。然而,皮肤BCC中闭合蛋白的表达仍不清楚。因此,我们通过免疫组织化学(IHC)检测了BCC及相邻正常皮肤中闭合蛋白1和4的表达情况。我们的IHC结果显示,34例低级别BCC中有33例闭合蛋白1高表达,闭合蛋白4低表达。在低级别BCC中,与正常皮肤相比,闭合蛋白1增加,闭合蛋白4减少。闭合蛋白1倾向于在肿瘤巢周边的肿瘤细胞膜和细胞质中高表达。相反,几乎所有低级别BCC(33/34)和2例高级别BCC中的1例闭合蛋白4缺乏或呈局灶性阳性。这些结果表明,这种表达模式是低风险BCC的特征。有趣的是,2例高级别BCC中的1例表现出相反的闭合蛋白表达模式,闭合蛋白1减少,闭合蛋白4增加。免疫组织化学检测闭合蛋白1和4的表达组合可能为BCC的病理诊断提供一种有用的辅助工具。此外,膜性和细胞内的闭合蛋白可能为无法控制的BCC提供未来的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad08/9883106/7da1b4ff7839/DRP2023-9936551.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验